-
Novocure's Stock Gains 3% As Anthem Now Covers Optune For Its Members
Friday, February 12, 2016 - 9:01am | 240Read More...Shares of Novocure Ltd (NASDAQ: NVCR) were trading higher by more than 3 percent early Friday morning after the company announced that Anthem Inc (NYSE: ANTM) will begin covering its Optune therapy for members. Novocure's Optune is a portable, noninvasive device that delivers Tumor Treating...
-
Here's Why Novocure Is Having A Huge Day
Monday, November 23, 2015 - 2:19pm | 400Read More...Shares of Novocure Ltd (NASDAQ: NVCR) surged higher on Monday by more than 10 percent. Novocure announced new Phase 3 data, in which patients who received the company's Optune in combination with bevacizumab at first recurrence lived "significantly longer" than those who just received bevacizumab...
